Skip to main content
| News

Patients stand to benefit from innovative tech project

11.12.2020

The investment and innovation promotion agency Basel Area Business & Innovation is joining forces with several partners to realize a technology project. For this, an app aimed at supporting oncology patients is being developed.

Version under development of the app for patients of the Hospital of Jura

The Hospital of Jura (H-JU) will be realizing four joint projects together with Basel Area Business & Innovation over the next four years. For the first, the two partners have also brought on board the University Hospital Basel (USB) and Haute Ecole Arc (HE-Arc). For this inter-cantonal technology project, an app is being developed for oncology patients. This is aimed at providing an improved overview of upcoming doctor’s appointments and treatments for users. The Swiss federal government and the canton of Jura have provided financial backing for the project, as detailed in a press release.

The patients in question from the canton of Jura are being treated at either the H-JU in Delémont or the USB in Basel. For this reason, an overview of appointments as well as information on the various institutions is important for the patients. The app should not only display these appointments and remind users of these, but will also be shared with other relatives. In addition, any entries and notifications about prescribed medication and treatments can be accessed here. The new app is rounded off by providing further information on the respective illness. In this way, individual information can be sent to the patient, which should also lead to faster reactions.

Basel Area Business & Innovation is the initiator of the project and will also be responsible for coordinating it. Given that the relevant pre-planning has already been carried out with developers, software ergonomics specialists and engineering students from HE-Arc at Switzerland Innovation Park Basel Area in Courroux in the canton of Jura, the test phase is set to begin before the end of this year. In a next step, a company from Jura will be tasked with developing a marketing concept. In future, the app should be available for other hospitals and medical practices, including for other medical disciplines.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Databaum establishes headquarters in Basel
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
New innovation campus opens in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
VectivBio raises 125 million US dollars in stock sale
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.